Tender Details

Country: Poland
Summary: The Service of Acting as a Cro (Clinical Research Organization) as Part of the Implemented Project: "Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately-To-Severely Active Ulce...
PLT Ref No: 97670869
Deadline: 26 Mar 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 116359-2024
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The Service of Acting as a Cro (Clinical Research Organization) as Part of the Implemented Project: "Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately-To-Severely Active Ulcerative C...
The service of acting as a CRO (Clinical Research Organization) as part of the implemented project: "Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis - the head to head COMBO-UC trial"
The subject of the order is the service of acting as a CRO (Clinical Research Organization) as part of the ongoing project: "Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis - the head to head COMBO-UC trial", 2022/ABM/03/00013, financed by the Agency Medical Research.
Detailed descriptionsubject of the order is Annex No. 2 to the SWZ.
The contractor is obliged to complete the order on the terms and conditions described in the Contract template constituting Annex No. 4 to the SWZ.
The service of acting as a CRO (Clinical Research Organization) as part of the implemented project: "Comparison of mouthkinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis the head to head COMBO-UC trial"
The subject of the order is the service of acting as a CRO (Clinical Research Organization) as part of the implemented project: "Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis the head to head COMBO-UC trial", 2022/ABM/03/00013, financed by the Medical Research Agency.
A detailed description of the subject of the order is attached as Annex No. 2 to the SWZ.
The contractor is obliged to complete the order for ...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

The Service of Acting as a Cro (Clinical Research Organization) as Part of the Implemented Project: "Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately-To-Severely Active Ulce... - Poland Tender

The MEDICAL UNIVERSITY OF LODZ, a Government sector organization in Poland, has announced a new tender for The Service of Acting as a Cro (Clinical Research Organization) as Part of the Implemented Project: "Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately-To-Severely Active Ulce.... This tender is published on PolandTenders under PLT Ref No: 97670869 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-03-26.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.